Figure 1. Biochemical and Structural Analysis of the EGL-1/CED-9 Complex
(A) Summary of binding studies between CED-9 (residues 1-251) and various EGL-1 fragments. The C-terminal half of EGL-1 (residues 45-87) was found to be necessary and sufficient for binding to CED-9. (B) Overall structure of an EGL-1/CED-9 complex. CED-9 and EGL-1 are colored cyan and pink, respectively. Only 27 amino acids of EGL-1 (47-73) contribute to CED-9 binding and are visible in the electron density map. (C) Measurement of binding affinities between EGL-1 and CED-9 by isothermal titration calorimetry (ITC). Shown here is a representative ITC run between CED-9 (residues 68-251) and EGL-1 (48-72). Data fitting revealed a binding affinity of 6.4 nM, similar to that between CED-9 and the full-length EGL-1. lar fold, resembling a single folding unit ( Figure 1B) . this surface cleft, residues on helix ␣4 of CED-9 are translocated over a distance of 8-12 Å ( Figure 2B ). This CED-9 comprises seven ␣ helices, with the central hydrophobic helix ␣5 surrounded by six helices and several unusual conformational flexibility might underlie the critical functions of CED-9 and other Bcl-2 family proteins. surface loops. A 27 amino acid fragment of the EGL-1 protein (residues 47-73) forms a single amphipathic ␣ The conformational change observed in the EGL-1/ CED-9 complex is quite different from that reported in helix, packing against CED-9 helices ␣2, ␣3, ␣4, ␣5, and ␣7 over an extended hydrophobic surface cleft (Figure the mammalian complexes involving Bcl-xL. In those cases, the change primarily involves a lateral movement 1B). Residues N-or C-terminal to the EGL-1 helix were disordered in the crystals and thus are not involved in of helix ␣3, such as that in the Bak-BH3/Bcl-xL complex (Sattler et al., 1997). However, in the EGL-1/CED-9 combinding to CED-9. To confirm that these regions of EGL-1 do not contribute to CED-9 binding, we examined the plex, helix ␣3 remains nearly unchanged before and after EGL-1 binding, yet helix ␣4 undergoes drastic structural binding affinities between CED-9 and various fragments of EGL-1 using isothermal titration calorimetry (ITC). The rearrangements ( Figure 2B ). In addition, the EGL-1/ CED-9 interface is more extensive than that of the reresults revealed that the EGL-1 fragment (residues 48-72) binds to CED-9 (residues 68-251) with a dissociation ported mammalian complexes involving Bcl-xL and a Compared to the free CED-9 protein, EGL-1-bound CED-9 undergoes significant structural rearrangements,
The EGL-1/CED-9 Interface The driving force for the binding of EGL-1 to CED-9 is van leading to the exposure of an extended hydrophobic surface cleft (Figure 2A ). Nonpolar residues from the der Waals interactions. Nine hydrophobic side chains as well as two glycine residues (Gly51 and Gly55) from the amphipathic EGL-1 helix interact with this hydrophobic surface cleft on CED-9. This interaction results in the amphipathic EGL-1 helix make extensive contacts to the hydrophobic surface cleft on CED-9 ( Figure 3A) . At burial of 2454 Å 2 exposed surface area. To configure the N-terminal portion of the EGL-1 helix, two isoleucines (Ile50 and Ile54) and two glycines (Gly51 and Gly55) stack against the wedge between helices ␣3 and ␣4 of CED-9 ( Figure 3A) . At the center of the interface, Phe65 of EGL-1 is nestled in a hydrophobic pocket formed by CED-9 residues Met119, Phe123, Lys126, Ile 172, and respectively ( Figure 3A) . The key residues of EGL-1 that interact with CED-9 are highly conserved between C. elegans and C. briggsae, two related nematodes species ( Figure 3B ). Interestwith glutathione S-transferase (GST), and their interactions with CED-9 were investigated using a GST-mediingly, residues from the predicted BH3 domain (Leu58-Asp66) only contribute to approximately half of the ated pull-down assay ( Figure 3C ). Consistent with the observed structural features, substitution of a bulky hyobserved interactions and one-third of the extended EGL-1 helix ( Figure 3B ). This structural finding nicely drophobic residue (Leu58, Met61, Phe65, or Met69) by Ala in EGL-1 did not significantly affect its interaction explains the observation that the EGL-1 BH3 peptide does not stabilize the CED-9 protein to the same extent with CED-9 ( Figure 3C , lanes 8 and 10-13). Strikingly, substitution of Gly55 by a negatively charged glutamate as the intact EGL-1 protein (Woo et al., 2003) .
residue was not sufficient to abolish interaction with CED-9 (lane 9). Nonetheless, a double mutant (mut2, Biochemical and Functional Analyses of EGL-1/CED-9 Interactions G55E/F65A) and a quadruple mutant (mut4, G55E/L58A/ F65A/M69A) failed to bind to CED-9 (lanes 4, 6, and 7). To corroborate our structural analysis, we examined whether mutations on the interface residues of EGL-1 These results are consistent with the structural observation that the intimate interface between EGL-1 and could weaken or disrupt its binding to CED-9. Various mutant EGL-1 fragments were purified as fusion proteins CED-9 closely resembles the interior of a single folded protein and is thus relatively resistant to single mis-(mut2, G55E/F65A) and quadruple mutant (mut4, G55E/ L58A/F65A/M69A) completely failed to disrupt the CEDsense mutations.
EGL-1 induces apoptosis by displacing CED-4 from 4/CED-9 complex (lanes 3, 5, 12, and 13). Interestingly, some EGL-1 mutants, such as G55E and L58A, while the CED-4/CED-9 complex. To recapitulate this finding in vitro, we reconstituted a CED-4 displacement assay retaining their ability to bind to CED-9 ( Figure 3C ), exhibited significantly reduced ability in displacing CED-4 in which preassembled CED-4/CED-9 complex was immobilized on glutathione resin and was then challenged from the CED-4/CED-9 complex in vitro ( Figure 3D, lanes  7 and 8) . Hence, the ability of an EGL-1 mutant to disrupt with various EGL-1 fragments ( Figure 3D ). After extensive washing, the remaining CED-4/CED-9 complex was the CED-4/CED-9 complex provides a sensitive and biologically meaningful evaluation of the effect of the EGL-1 eluted from the resin and visualized on an SDS polyacrylamide gel. As anticipated, the wild-type EGL-1 protein missense mutation on its function. Our in vitro studies ( Figures 3C and 3D ) are in complete agreement with the (residues 1-87) or the C-terminal fragment of EGL-1 (45-87) completely displaced CED-4 from the CED-4/CED-9 structural observation ( Figure 3A) . If these EGL-1 mutants were less able to disrupt the complex ( Figure 3D, lanes 2 and 4) . In contrast, most missense mutations at the EGL-1/CED-9 interface CED-4/CED-9 complex, then they should exhibit decreased ability to induce cell death compared to the WT weakened the ability of EGL-1 to displace CED-4 from the CED-4/CED-9 complex. Notably, the double mutant EGL-1 protein.
To examine this scenario, we injected 3C) yet exhibited a decreased ability to disrupt the CED- 
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G55E and F65D
To further define the molecular mechanisms by which with at least 30% of its surface area exposed to solvent.
1-45
We grouped these 44 amino acids based on primary Interestingly, although these mutations affect residues into ced-1 (e1735); egl-1 (n1084 n3082) animals conwidely separated in the primary sequence, they are structs that direct expression of various EGL-1 fragmapped to the same surface patch on CED-9, defining ments under the control of the C. elegans heat-shock a surface motif important for CED-4 binding ( Figure 4A ). promoters. Cell corpses were scored in the anterior head We believe that this surface patch constitutes the priregion of 4-fold transgenic embryos after the heat-shock mary CED-4 binding motif, because none of the other treatment (see Experimental Procedures). Few cell corpses 16 mutations affected the CED-4/CED-9 interaction, and were observed in the ced-1 (e1735); egl-1 (n1084 n3082) they cover the rest of the CED-9 surface. We also conembryos because the egl-1 (n1084 n3082) mutation firmed a previous observation in which a missense mutablocks almost all somatic cell deaths (Conradt and Hortion in CED-9, Y149N (n1653ts), was found to weaken vitz, 1998). As shown previously (Conradt and Horvitz, the CED-4/CED-9 interactions (Hengartner et al., 1992) 1998), expression of the full-length EGL-1 protein in-( Figure 4B, lane 10) . On the CED-9 structure, however, duced robust cell killing (Table 2) . Interestingly, expresTyr149 is deeply buried in the hydrophobic core. Resion of the EGL-1 fragment (residues 46-87) induced flecting its structural role, CED-9 (Y149N) protein exhibabout half the number of cell corpses as the full-length its poor solubility, has a strong tendency to aggregate, EGL-1, indicating that this EGL-1 fragment is functional and is prone to proteolysis ( Figure 4B , lane 10). in vivo. In contrast, expression of EGLl-1 (residues 1-45) did not induce cell death, consistent with an earlier observation (Conradt and Horvitz, 1998). In vitro, the G55E A Working Model of How EGL-1 Disrupts CED-9/CED-4 Interactions mutation in EGL-1 significantly reduced its ability to disrupt the CED-4/CED-9 complex ( Figure 3D ). AccordOur structure-based biochemical analysis revealed that CED-9 employs two distinct surface areas for its interacingly, EGL-1 (G55E) is a very weak cell death inducer in vivo (Table 2) . tion with EGL-1 and CED-4. CED-9 residues that are in direct contact with EGL-1 are not involved in binding to The cell-killing activity of various EGL-1 mutants correlated extremely well with their in vitro biochemical CED-4 (Figures 3 and 4) . EGL-1 binds to a hydrophobic surface cleft of CED-9; however, this hydrophobic cleft activities in binding to CED-9 and in displacing CED-4 from the CED-4/CED-9 complex. For example, in vitro, is absent in the free CED-9 protein and is only formed after major structural rearrangements induced by EGL-1 the EGL-1 double mutant (G55E/F65A) failed to bind to CED-9 ( Figure 3C ) or to displace CED-4 from the CEDbinding. These structural rearrangements primarily involve the ␣4 helix of CED-9 and the loop immediately 4/CED-9 complex (Figure 3D) , whereas the EGL-1 (G55E) mutant retained its ability to interact with CED-9 ( Figure  following ␣4 (Figure 2B) . Interestingly, an important part . At the onset of programmed cell death, the EGL-1 protein is expressed and binds to dues 158-160 ( Figure 4B ), maps to this loop. This observation indicates that the binding of EGL-1 to CED-9 will CED-9. The drastic conformational changes in the ␣4 loop region of CED-9 induced by EGL-1 binding results inevitably induce a drastic rearrangement of the loop following helix ␣4 and thus destabilize the binding of in the disruption of the CED-4/CED-9 complex, because the specific conformation of EGL-1-bound CED-9 is not CED-4 to CED-9, leading to the release of CED-4 from the CED-4/CED-9 complex. compatible with that required for binding to CED-4 (Figure 4C ). These data and analyses strongly suggest a working model by which EGL-1 displaces CED-4 from the CEDThis model is supported by our structural and biochemical analyses and explains a body of published 4/CED-9 complex ( Figure 4C ). In this model, CED-4 binds to a surface area of CED-9 that is next to the observations. For example, G169E in CED-9 was a gainof-function mutation (Hengartner and Horvitz, 1994a). EGL-1 binding element. This interaction allows CED-9 to sequester CED-4 to the outer membrane of mitochonThis mutation affects a small residue that is in the EGL-1
